The Meat Institute is applauding the House of Representatives for passing the Support for Patients and Communities Reauthorization Act that, in part, fights the illicit use of xylazine in humans while preserving access to the drug for use in animals.
“For beef packers, xylazine is used to quickly and humanely sedate sick or injured cattle in a manner that can safely and effectively be administered by workers. Xylazine has both animal welfare and worker safety benefits at beef plants, and there are no equally safe and effective alternatives,” said Meat Institute President and CEO Julie Anna Potts.